65642 Federal Register / Vol. 75, No. 206 / Tuesday, October 26, 2010 / Notices 

at least 7 days in advance of the 

meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/ 

AdvisoryCommittees/ 

AboutAdvisoryCommittees/ 

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: October 21, 2010. 

Jill Hartzler Warner, 

Acting Associate Commissioner for Special 

Medical Programs. 

[FR Doc. 2010–27008 Filed 10–25–10; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; HIV/ 

AIDS Behavioral Treatment Intervention and 

Services Development-Member Conflict. 

Date: November 12, 2010. 

Time: 9:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call) 

Contact Person: Enid Light, PhD, Scientific 

Review Officer, Division of Extramural 

Activities, National Institute of Mental 

Health, NIH, Neuroscience Center, 6001 

Executive Boulevard, Room 6132, MSC 9608, 

Bethesda, MD 20852, 301–443–3599, 

elight@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: October 18, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26959 Filed 10–25–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the Council of Councils, 

November 8, 2010, 9 a.m. to November 

8, 2010, 3 p.m., National Institutes of 

Health, Building 31, 31 Center Drive, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

September 30, 2010, 75 FR 60465. 

This Federal Register Notice is 

amended to add a Closed Session from 

12:15 p.m. to 12:45 p.m. on November 

8, 2010. 

The meeting is partially closed to the 

public. 

Dated: October 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27051 Filed 10–25–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Listing of Members of the 

National Centers for Disease Control 

and Prevention’s 2010 Performance 

Review Board (PRB) 

AGENCY: The Centers for Disease Control 

and Prevention (CDC), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) 

announces the persons who will serve 

on the CDC’s 2010 Performance Review 

Board. This action is being taken in 

accordance with Title 5, U.S.C., 

4314(c)(4), which requires that members 

of performance review boards be 

appointed in a manner to ensure 

consistency, stability, and objectivity in 

performance appraisals and requires 

that notice of the appointment of an 

individual to serve as a member be 

published in the Federal Register. 

The following persons will serve on 

the CDC Performance Review Board, 

which is responsible for making 

recommendations on performance 

appraisal ratings, pay adjustments, and 

performance awards for CDC’s Senior 

Executive Service (SES) members: 

Kevin Fenton (Co-Chair), Lynn Austin 

(Co-Chair), Ed Hunter, Rima Khabbaz, 

Crayton Lankford, Carolyn Black, 

Christine Branche, Anne Haddix, 

Barbara Harris, Jim Seligman, Walter 

Harris, Hazel Dean, Bill Porter. 

For further information about the CDC 

Performance Review Board, contact the 

Centers for Disease Control and 

Prevention, Human Capital Management 

Office, Human Capital Planning Branch, 

1600 Clifton Road, NE., MS E–50, 

Atlanta, GA 30333. Telephone (404) 

498–6709 (not a toll free number). 

Dated: October 20, 2010. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2010–26999 Filed 10–25–10; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0511] 

Withdrawal of Approval of New Animal 

Drug Applications; Aklomide; 

Levamisole Hydrochloride; Nitromide 

and Sulfanitran 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is withdrawing 

approval of eight new animal drug 

applications (NADAs). In a final rule 

published elsewhere in this issue of the 

Federal Register, FDA is amending the 

animal drug regulations to remove 

portions reflecting approval of these 

NADAs. 

DATES: Withdrawal of approval is 

effective November 5, 2010. 

FOR FURTHER INFORMATION CONTACT: John 

Bartkowiak, Center for Veterinary 

Medicine (HFV–212), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9079, 

e-mail: john.bartkowiak@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Fort 

Dodge Animal Health, a Division of 

Wyeth Holdings, a Wholly Owned 

Subsidiary of Pfizer, Inc., 235 East 42d 


emcdonald on DSK2BSOYB1PROD with NOTICES